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presented with a 2-day history of upper abdominal pain,
nausea, and vomiting. On clinical examination, she was
found to have low blood pressure and upper abdominal
tenderness. Her abdominal ultrasound was normal except
for an intrauterine fetal death. However, computed
tomography (CT) scan showed mild pancreatic swelling
without hemorrhage or destruction.
A 34-year-old woman (patient 2) presented with a 6-day
history of paroxysmal abdominal pain and a 3-day history of
nausea and vomiting. On physical examination, no signifi-
cant abnormalities were found. Abdominal ultrasound and
CT scan were normal.
A 29-year-old man (patient 3) presented with a 7-day
history of polydipsia and polyuria and a 3-day history
of fever and headache. On admission, clinical exami-
nation was normal except for a 116 beats/min regular
pulse. No abnormalities were observed on abdominal
ultrasonography.
None of the patients had past or family histories of
diabetes. Laboratory data are shown in Table 1. The
patients were all treated immediately as diabetic ketoaci-
dosis. In addition, patient 1 was suspected to have acute* Corresponding author. Department of Endocrinology, First
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doi:10.1016/j.jfma.2011.08.034pancreatitis. Thus, fasting and fluid replacement therapy
were also performed. All of them made excellent recovery.
However, 52e55 IU/day of insulin were needed to maintain
their normal glucose levels afterwards.
Fulminant type 1 diabetes is characterized by remark-
ably abrupt onset of ketosis or ketoacidosis, complete
destruction of pancreatic beta cells, high plasma glucose
concentrations, and relatively low HbA1c levels at diag-
nosis. The disease was temporarily classified as type 1B
diabetes.1 Transient Glutamic Acid Decarboxylase Antibody
(GADAb) at a low titer, however, was detected in a small
proportion of such patients, indicating that autoimmune
mechanism may, at least partially, contribute to the onset
of the disease.2
Identification of fulminant type 1 diabetes was difficult.
Some of its characteristics, such as age, symptoms, serum
pancreatic enzymes, and islet-related autoantibodies,
were quite distinct from classic type 1A diabetes. In most
cases, ultrasonography and CT scan showed no abnormali-
ties of pancreas.3 Exceptional cases, however, presented
with not only an elevation of pancreatic enzymes, but also
a pancreatic swelling.4 In this case, differentiating the
disease from acute pancreatitis was important. The
following factors may support a diagnosis of fulminant type
1 diabetes: (1) common causes of acute pancreatitis such as
gallstones and alcohol were absent; (2) abdominal symp-
toms were not as long-standing as in acute pancreatitis; (3)
pancreatic islet function was almost completely destroyed;
however, only mild abnormalities of pancreatic images
were observed; (4) symptoms and laboratory data subsided& Formosan Medical Association. All rights reserved.
Table 1 Clinical and laboratory findings of the patients on
admission.
Patient 1 Patient 2 Patient 3
Age/sex 25/F 34/F 29/M
BMI (kg/m2) 21.7 20.4 21.5
Duration (d) 2 6 7
Family history e e e
Thirst e e þ
Flu-like symptoms e e þ
Abdominal symptoms þ þ e
Pregnancy þ e e
Blood chemistry
plasma glucose
concentration
(mmol/L)
36.2 22.4 42.1
HbA1c (%) 6.2 7.9 8.1
PH 7.147 6.978 7.203
HCO3
e (mmol/L) 9.2 6.7 5.5
ALT (U/L) 47 49 37
AST (U/L) 33 47 34
BUN (mmol/L) 3.9 4.2 4.1
Cr (umol/L) 66 74 109
Na (mmol/L) 134.5 126.8 127.5
K (mmol/L) 3.11 4.9 4.36
TG (mmol/L) 1.96 ND 0.97
TCHOL (mmol/L) 3.5 ND 2.8
Serum amylase (U/L) 259 347 ND
Urine amylase (U/L) 439 ND ND
Serum CPR (ng/mL) <0.06 <0.1 <0.06
Serum CPR after
glucagon load (ng/mL)
<0.06 <0.1 <0.06
Immunologic tests
GADAb e e e
ICA ND ND e
BMI Z Body Mass Index; BUN Z Blood Urea Nitrogen;
CPR Z C-peptide; GADAb Z Glutamic Acid Decarboxylase
Antibody; ICAZ Islet Cell Autoantibody; NDZ Not Determined;
TG Z Triglyceride; TCHOL Z Total Cholesterol.
364 J. Fu, B.-Y. Shiby treatment for ketoacidosis; (5) lifelong injection of
exogenous insulin was inevitable, and the mean insulin
dosages were significantly high.
Association with pregnancy is another feature.
A nationwide survey in Japan revealed that almost
all female patients who developed diabetes during
pregnancy or just after delivery were fulminant type 1
diabetes.2 Moreover, pregnancy-associated fulminant
type 1 patients suffered from more severe clinical
courses and poor prognosis of their fetuses.5 Patient 1,
in our report, suffered from an intrauterine fetal
death. Thus, it is important for all medical practi-
tioners, not only endocrinologists, to make a correct
diagnosis of the disease and begin reasonable treat-
ment as early as possible.Acknowledgment
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